The Vanguard Group Discloses Position in Spire Healthcare Group

On February 5, 2026, The Vanguard Group, Inc. disclosed its position concerning Spire Healthcare Group plc, in compliance with Rule 8.3 of the Takeover Code. The disclosure indicates that Vanguard controls 14,429,263 1p ordinary shares, representing 3.58% of Spire Healthcare. The position was recorded as of February 4, 2026.

Transactions involving Spire's securities have been reported by Vanguard. This includes the purchase of 2,190 shares at 2.04 GBP per share and the sale of 2,320 shares at the same price. No cash-settled derivative transactions or exercises of stock options were noted. Additionally, there are no arrangements or understandings regarding securities voting rights or acquisitions with other parties.